Please do not adjust margins
Organic & Biomolecular Chemistry
Page 6 of 8
DOI: 10.1039/C8OB01952E
ARTICLE
Journal Name
6
7
8
9
X. Tang, J. Swaminathan, A. M. Gewirtz and I. J. Dmochowski,
Nucleic Acids Res., 2008, 36, 559-569.
L. Wu, F. Pei, J. Zhang, J. Wu, M. Feng, Y. Wang, H. Jin, L.
Zhang and X. Tang, Chem.-Eur. J., 2014, 20, 12114-12122.
P. K. Jain, S. Shah and S. H. Friedman, J. Am. Chem. Soc.,
2011, 133, 440-446.
propidium iodide (0.1 mg/mL) for 30 min at 37
℃ in the dark.
The cells were analyzed using a flow cytometry (BDFACSAria
Ⅱ
). The percentage of cells in the G2/M phase of the cell cycle
was evaluated using the software ModFitLT 5.0.
L. Shah, S. T. Laughlin and I. S. Carrico, J. Am. Chem. Soc.,
2016, 138, 5186-5189.
Conclusions
10 S. Shah, S. Rangarajan and S. H. Friedman, Angew. Chem. Int.
Ed., 2005, 44, 1328-1332.
In summary, we developed a series of caged siRNAs with single
folic acid modification and photolinker at 5′ end of antisense 11 J. Soutschek, A. Akinc, B. Bramlage, K. Charisse, R. Constien,
M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth,
M. John, V. Kesavan, G. Lavine, R. K. Pandey, T. Racie, K. G.
Rajeev, I. Rohl, I. Toudjarska, G. Wang, S. Wuschko, D.
Bumcrot, V. Koteliansky, S. Limmer, M. Manoharan and H.-P.
Vornlocher, Nature, 2004, 432, 173-178.
strand RNA. These FA modified caged siRNAs were synthesized
directly on solid phase resin by subsequent coupling of the
photolinker and activated folic acid NHS ester, and further
purified by RP HPLC and characterized by ESI mass spectra.
Folic acid modified caged RNA showed slower mobility than 12 T. C. Roberts, K. Ezzat, S. EL Andaloussi and M. S. Weinberg,
in siRNA Delivery Methods: Methods and Protocols, eds. K.
Shum and J. Rossi, Springer New York, New York, NY, 2016,
DOI: 10.1007/978-1-4939-3112-5_23, pp. 291-310.
13 F. Debart, C. Dupouy and J.-J. Vasseur, Beilstein J. Org.
Chem., 2018, 14, 436-469.
the corresponding unmodified RNA in PAGE gel. Light
irradiation cleaved the photolinker and removed folic acid
moiety, and further restored RNA mobility. Results from
confocal laser scanning microscopy and flow cytometry
showed that the cellular uptake ability of siRNA increased with 14 Q. N. Nguyen, R. V. Chavli, J. T. Marques, P. G. Conrad Ii, D.
Wang, W. He, B. E. Belisle, A. Zhang, L. M. Pastor, F. R.
Witney, M. Morris, F. Heitz, G. Divita, B. R. G. Williams and G.
K. McMaster, BBA - Biomembranes, 2006, 1758, 394-403.
15 Y. Ji, J. Yang, L. Wu, L. Yu and X. Tang, Angew. Chem. Int. Ed.,
2016, 55, 2152-2156.
the attachment of single folic acid moiety, but still need
transfection agents to assist their efficient delivery and
effective release for further gene silencing. With the
attachment of single folic acid at 5′ end of antisense strand
RNA, FA modified caged siRNA was nearly inert due to the 16 J. Yang, C. Chen and X. Tang, Bioconjugate Chem., 2018, 29
,
1010-1015.
17 L. Yu, D. Liang, C. Chen and X. Tang, Biomacromolecules,
2018, 19, 2526-2534.
18 Z. Liangliang, C. Changmai, F. Xinli and T. Xinjing,
ChemBioChem, 2018, 19, 1259-1263.
steric blocking effect on RISC formation or processing. Light
irradiation quickly recovered the active siRNA and triggered
RNAi induced gene silencing machinery. With this caging
strategy, both the exogenous gene (GFP) and endogenous
gene (Eg5) were successfully achieved using these caged 19 Y. Hattori and Y. Maitani, J. Controlled Release, 2004, 97
,
173-183.
siRNAs with single folic acid modification at 5' end of antisense
strand RNA. This modification strategy proves a clue for
practical applications to photomodulate RNAi induced gene
silencing in future.
20 E. Nogueira, A. C. Gomes, A. Preto and A. Cavaco-Paulo,
Nanomedicine: Nanomed-Nanotechnol, 2016, 12, 1113-1126.
21 P. S. Low, W. A. Henne and D. D. Doorneweerd, Accounts
Chem. Res., 2008, 41, 120-129.
22 S. Sabharanjak and S. Mayor, Adv. Drug Delivery Rev., 2004,
56, 1099-1109.
23 C. Hu, Z. Wu, H. Tang, L.-J. Tang, R.-Q. Yu and J.-H. Jiang, Int. J.
Mol. Sci., 2014, 15, 5221-5232.
24 R. Schneider, F. Schmitt, C. Frochot, Y. Fort, N. Lourette, F.
Guillemin, J.-F. Müller and M. Barberi-Heyob, Bioorgan. Med.
Chem., 2005, 13, 2799-2808.
Conflicts of interest
There are no conflicts to declare
25 S. Wang, R. J. Lee, C. J. Mathias, M. A. Green and P. S. Low,
Bioconjugate Chem., 1996, 7, 56-62.
This work was supported by National Major Scientific and 26 R. Xie, S. Hong, L. Feng, J. Rong and X. Chen, J. Am. Chem.
Acknowledgements
Soc., 2012, 134, 9914-9917.
27 D. Feng, Y. Song, W. Shi, X. Li and H. Ma, Anal. Chem., 2013,
85, 6530-6535.
28 M. Thomas, S. A. Kularatne, L. Qi, P. Kleindl, C. P. Leamon, M.
J. Hansen and P. S. Low, Ann. N. Y. Acad. Sci., 2009, 1175, 32-
39.
Technological Special Project for “Significant New Drugs
Development” (Grant No. 2017ZX09303013) and the National
Science Foundation of China (Grant NO: 21422201, 21372018,
and 21672015).
29 C. Dohmen, T. Fröhlich, U. Lächelt, I. Röhl, H.-P. Vornlocher,
P. Hadwiger and E. Wagner, Mol. Ther.-Nuc. Acids, 2012, 1,
e7.
30 J. M. Govan, D. D. Young, H. Lusic, Q. Liu, M. O. Lively and A.
Deiters, Nucleic Acids Res., 2013, 41, 10518-10528.
31 T. M. Kapoor and T. J. Mitchison, J. Cell Biol., 2001, 154,
1125-1133.
32 M. J. Damha and K. K. Ogilvie, in Protocols for
Oligonucleotides and Analogs: Synthesis and Properties, ed.
S. Agrawal, Humana Press, Totowa, NJ, 1993, DOI:
10.1385/0-89603-281-7:81, pp. 81-114.
Notes and references
1
N. Ankenbruck, T. Courtney, Y. Naro and A. Deiters, Angew.
Chem. Int. Ed., 2017, 57, 2768-2798.
2
C. Chen, Z. Yang and X. Tang, Med. Res. Rev., 2018, 38, 829-
869.
3
4
V. Mikat and A. Heckel, RNA, 2007, 13, 2341-2347.
C. M. Connelly, R. Uprety, J. Hemphill and A. Deiters, Mol.
Biosyst., 2012, 8, 2987-2993.
5
B. K. Ruble, S. B. Yeldell and I. J. Dmochowski, J. Inorg.
Biochem., 2015, 150, 182-188.
6 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins